Literature DB >> 24271014

Sun exposure causes somatic second-hit mutations and angiofibroma development in tuberous sclerosis complex.

Magdalena E Tyburczy1, Ji-An Wang, Shaowei Li, Rajesh Thangapazham, Yvonne Chekaluk, Joel Moss, David J Kwiatkowski, Thomas N Darling.   

Abstract

Tuberous sclerosis complex (TSC) is characterized by the formation of tumors in multiple organs and is caused by germline mutation in one of two tumor suppressor genes, TSC1 and TSC2. As for other tumor suppressor gene syndromes, the mechanism of somatic second-hit events in TSC tumors is unknown. We grew fibroblast-like cells from 29 TSC skin tumors from 22 TSC subjects and identified germline and second-hit mutations in TSC1/TSC2 using next-generation sequencing. Eighteen of 22 (82%) subjects had a mutation identified, and 8 of the 18 (44%) subjects were mosaic with mutant allele frequencies of 0 to 19% in normal tissue DNA. Multiple tumors were available from four patients, and in each case, second-hit mutations in TSC2 were distinct indicating they arose independently. Most remarkably, 7 (50%) of the 14 somatic point mutations were CC>TT ultraviolet 'signature' mutations, never seen as a TSC germline mutation. These occurred exclusively in facial angiofibroma tumors from sun-exposed sites. These results implicate UV-induced DNA damage as a cause of second-hit mutations and development of TSC facial angiofibromas and suggest that measures to limit UV exposure in TSC children and adults should reduce the frequency and severity of these lesions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24271014      PMCID: PMC3959815          DOI: 10.1093/hmg/ddt597

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  18 in total

1.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

Authors:  Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo
Journal:  Genome Res       Date:  2010-07-19       Impact factor: 9.043

Review 2.  Inherited susceptibility to common cancers.

Authors:  William D Foulkes
Journal:  N Engl J Med       Date:  2008-11-13       Impact factor: 91.245

3.  Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions.

Authors:  E P Henske; B W Scheithauer; M P Short; R Wollmann; J Nahmias; N Hornigold; M van Slegtenhorst; C T Welsh; D J Kwiatkowski
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

4.  Human TSC2-null fibroblast-like cells induce hair follicle neogenesis and hamartoma morphogenesis.

Authors:  Shaowei Li; Rajesh L Thangapazham; Ji-An Wang; Sangeetha Rajesh; Tzu-Cheg Kao; Leonard Sperling; Joel Moss; Thomas N Darling
Journal:  Nat Commun       Date:  2011       Impact factor: 14.919

5.  Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma.

Authors:  Nisreen El-Hashemite; Hongbing Zhang; Elizabeth P Henske; David J Kwiatkowski
Journal:  Lancet       Date:  2003-04-19       Impact factor: 79.321

6.  Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies.

Authors:  Connie G Glasgow; Wendy K Steagall; Angelo Taveira-Dasilva; Gustavo Pacheco-Rodriguez; Xiong Cai; Souheil El-Chemaly; Marsha Moses; Thomas Darling; Joel Moss
Journal:  Respir Med       Date:  2010-07       Impact factor: 3.415

7.  Ultra deep sequencing detects a low rate of mosaic mutations in tuberous sclerosis complex.

Authors:  Wei Qin; Piotr Kozlowski; Bruce E Taillon; Pascal Bouffard; Alison J Holmes; Pasi Janne; Susana Camposano; Elizabeth Thiele; David Franz; David J Kwiatkowski
Journal:  Hum Genet       Date:  2010-02-18       Impact factor: 4.132

8.  Integrative genomics viewer.

Authors:  James T Robinson; Helga Thorvaldsdóttir; Wendy Winckler; Mitchell Guttman; Eric S Lander; Gad Getz; Jill P Mesirov
Journal:  Nat Biotechnol       Date:  2011-01       Impact factor: 54.908

9.  MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development.

Authors:  Shaowei Li; Fumiko Takeuchi; Ji-an Wang; Christopher Fuller; Gustavo Pacheco-Rodriguez; Joel Moss; Thomas N Darling
Journal:  J Exp Med       Date:  2005-08-29       Impact factor: 14.307

10.  Fast and accurate long-read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2010-01-15       Impact factor: 6.937

View more
  36 in total

Review 1.  The Lymphangioleiomyomatosis Lung Cell and Its Human Cell Models.

Authors:  Wendy K Steagall; Gustavo Pacheco-Rodriguez; Thomas N Darling; Olga Torre; Sergio Harari; Joel Moss
Journal:  Am J Respir Cell Mol Biol       Date:  2018-06       Impact factor: 6.914

2.  A diagnostic and management algorithm for individuals with an isolated skin finding suggestive of tuberous sclerosis complex.

Authors:  N Nathan; K Burke; J Moss; T N Darling
Journal:  Br J Dermatol       Date:  2016-10-18       Impact factor: 9.302

Review 3.  New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complex.

Authors:  Hilaire C Lam; Julie Nijmeh; Elizabeth P Henske
Journal:  J Pathol       Date:  2016-11-29       Impact factor: 7.996

4.  Clinical Characteristics of Connective Tissue Nevi in Tuberous Sclerosis Complex With Special Emphasis on Shagreen Patches.

Authors:  Michelle A Bongiorno; Neera Nathan; Oyetewa Oyerinde; Ji-An Wang; Chyi-Chia Richard Lee; G Thomas Brown; Joel Moss; Thomas N Darling
Journal:  JAMA Dermatol       Date:  2017-07-01       Impact factor: 10.282

Review 5.  Mosaic Disorders of the PI3K/PTEN/AKT/TSC/mTORC1 Signaling Pathway.

Authors:  Neera Nathan; Kim M Keppler-Noreuil; Leslie G Biesecker; Joel Moss; Thomas N Darling
Journal:  Dermatol Clin       Date:  2017-01       Impact factor: 3.478

6.  Human Pluripotent Stem Cell-Derived TSC2-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis.

Authors:  Lisa M Julian; Sean P Delaney; Ying Wang; Alexander A Goldberg; Carole Doré; Julien Yockell-Lelièvre; Roger Y Tam; Krinio Giannikou; Fiona McMurray; Molly S Shoichet; Mary-Ellen Harper; Elizabeth P Henske; David J Kwiatkowski; Thomas N Darling; Joel Moss; Arnold S Kristof; William L Stanford
Journal:  Cancer Res       Date:  2017-08-22       Impact factor: 12.701

7.  A shower of second hit events as the cause of multifocal renal cell carcinoma in tuberous sclerosis complex.

Authors:  Magdalena E Tyburczy; Sergiusz Jozwiak; Izabela A Malinowska; Yvonne Chekaluk; Trevor J Pugh; Chin-Lee Wu; Robert L Nussbaum; Sara Seepo; Tomasz Dzik; Katarzyna Kotulska; David J Kwiatkowski
Journal:  Hum Mol Genet       Date:  2014-11-28       Impact factor: 6.150

Review 8.  Tuberous Sclerosis Complex: new criteria for diagnostic work-up and management.

Authors:  Sharon Samueli; Klaus Abraham; Anastasia Dressler; Gudrun Groeppel; Constanze Jonak; Angelika Muehlebner; Daniela Prayer; Andreas Reitner; Martha Feucht
Journal:  Wien Klin Wochenschr       Date:  2015-04-10       Impact factor: 1.704

9.  Potential Pitfalls in Pre-implantation Genetic Diagnosis in a Patient with Tuberous Sclerosis and Isolated Mosaicism for a TSC2 Variant in Renal Tissue.

Authors:  Kristin M Ikeda; Andrew A House; Dervla M Connaughton; Stephen E Pautler; Victoria Mok Siu; Michelle-Lee Jones
Journal:  Mol Syndromol       Date:  2021-03-09

10.  Improvement of tuberous sclerosis complex (TSC) skin tumors during long-term treatment with oral sirolimus.

Authors:  Neera Nathan; Ji-an Wang; Shaowei Li; Edward W Cowen; Mary Haughey; Joel Moss; Thomas N Darling
Journal:  J Am Acad Dermatol       Date:  2015-09-11       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.